Crinetics Net Invested Capital vs Accounts Payable Analysis

CRNX Stock  USD 57.20  0.47  0.81%   
Crinetics Pharmaceuticals financial indicator trend analysis is way more than just evaluating Crinetics Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Crinetics Pharmaceuticals is a good investment. Please check the relationship between Crinetics Pharmaceuticals Net Invested Capital and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.

Net Invested Capital vs Accounts Payable

Net Invested Capital vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Crinetics Pharmaceuticals Net Invested Capital account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Crinetics Pharmaceuticals' Net Invested Capital and Accounts Payable is 0.8. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Crinetics Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Crinetics Pharmaceuticals' Net Invested Capital and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Crinetics Pharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Invested Capital i.e., Crinetics Pharmaceuticals' Net Invested Capital and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.8
Relationship DirectionPositive 
Relationship StrengthStrong

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Accounts Payable

An accounting item on the balance sheet that represents Crinetics Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Crinetics Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Crinetics Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Crinetics Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.Selling General Administrative is likely to rise to about 61 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 188.1 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Income157K4.3M13.4M14.1M
Net Interest Income157K4.3M13.4M14.1M

Crinetics Pharmaceuticals fundamental ratios Correlations

0.870.990.990.50.880.950.9-0.17-0.980.780.520.910.910.17-0.811.00.950.880.84-0.810.560.830.880.74-0.92
0.870.90.890.850.810.691.00.2-0.850.520.21.00.98-0.16-0.940.850.980.640.59-0.940.850.580.70.36-0.63
0.990.91.00.560.920.920.92-0.06-0.990.740.420.930.920.13-0.840.990.970.850.83-0.840.630.770.880.69-0.89
0.990.891.00.530.920.920.91-0.03-0.990.790.390.920.890.16-0.830.980.960.860.85-0.830.620.790.880.72-0.9
0.50.850.560.530.50.240.830.48-0.470.06-0.140.810.81-0.53-0.830.470.730.190.14-0.830.910.140.34-0.17-0.14
0.880.810.920.920.50.80.820.21-0.890.680.110.830.80.11-0.760.870.870.660.73-0.760.60.680.780.59-0.79
0.950.690.920.920.240.80.73-0.39-0.930.840.670.740.760.36-0.630.970.820.930.88-0.630.290.920.850.88-0.98
0.91.00.920.910.830.820.730.17-0.880.560.221.00.98-0.13-0.940.880.990.680.63-0.940.830.610.730.41-0.67
-0.170.2-0.06-0.030.480.21-0.390.170.09-0.22-0.920.160.05-0.42-0.23-0.20.07-0.4-0.27-0.230.51-0.41-0.2-0.490.37
-0.98-0.85-0.99-0.99-0.47-0.89-0.93-0.880.09-0.81-0.43-0.89-0.86-0.20.78-0.98-0.93-0.89-0.90.78-0.59-0.77-0.9-0.770.93
0.780.520.740.790.060.680.840.56-0.22-0.810.430.580.510.51-0.390.790.650.880.91-0.390.140.860.640.92-0.88
0.520.20.420.39-0.140.110.670.22-0.92-0.430.430.240.340.35-0.160.540.320.660.5-0.16-0.170.640.480.64-0.62
0.911.00.930.920.810.830.741.00.16-0.890.580.240.98-0.11-0.940.890.990.70.65-0.940.820.620.740.43-0.68
0.910.980.920.890.810.80.760.980.05-0.860.510.340.98-0.19-0.920.890.970.650.6-0.920.780.630.750.4-0.67
0.17-0.160.130.16-0.530.110.36-0.13-0.42-0.20.510.35-0.11-0.190.20.19-0.010.510.420.2-0.470.50.010.59-0.43
-0.81-0.94-0.84-0.83-0.83-0.76-0.63-0.94-0.230.78-0.39-0.16-0.94-0.920.2-0.79-0.92-0.58-0.441.0-0.84-0.49-0.67-0.280.56
1.00.850.990.980.470.870.970.88-0.2-0.980.790.540.890.890.19-0.790.940.890.85-0.790.530.850.880.76-0.93
0.950.980.970.960.730.870.820.990.07-0.930.650.320.990.97-0.01-0.920.940.770.72-0.920.750.710.780.53-0.77
0.880.640.850.860.190.660.930.68-0.4-0.890.880.660.70.650.51-0.580.890.770.9-0.580.260.870.750.9-0.94
0.840.590.830.850.140.730.880.63-0.27-0.90.910.50.650.60.42-0.440.850.720.9-0.440.290.760.820.91-0.94
-0.81-0.94-0.84-0.83-0.83-0.76-0.63-0.94-0.230.78-0.39-0.16-0.94-0.920.21.0-0.79-0.92-0.58-0.44-0.84-0.49-0.67-0.280.56
0.560.850.630.620.910.60.290.830.51-0.590.14-0.170.820.78-0.47-0.840.530.750.260.29-0.840.080.54-0.03-0.27
0.830.580.770.790.140.680.920.61-0.41-0.770.860.640.620.630.5-0.490.850.710.870.76-0.490.080.570.83-0.86
0.880.70.880.880.340.780.850.73-0.2-0.90.640.480.740.750.01-0.670.880.780.750.82-0.670.540.570.73-0.88
0.740.360.690.72-0.170.590.880.41-0.49-0.770.920.640.430.40.59-0.280.760.530.90.91-0.28-0.030.830.73-0.94
-0.92-0.63-0.89-0.9-0.14-0.79-0.98-0.670.370.93-0.88-0.62-0.68-0.67-0.430.56-0.93-0.77-0.94-0.940.56-0.27-0.86-0.88-0.94
Click cells to compare fundamentals

Crinetics Pharmaceuticals Account Relationship Matchups

Crinetics Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets130.4M183.4M351.0M352.2M635.4M667.1M
Other Current Liab2.8M7.0M12.6M17.5M31.2M32.7M
Total Current Liabilities8.3M10.5M16.0M27.7M43.9M46.1M
Total Stockholder Equity(93.8M)(167.6M)(275.3M)(439.2M)539.1M566.1M
Net Tangible Assets117.1M168.9M331.9M316.3M363.8M382.0M
Property Plant And Equipment Net6.5M5.4M4.7M5.0M57.4M60.3M
Net Debt(35.5M)(89.1M)(197.6M)(30.6M)(3.2M)(3.3M)
Retained Earnings(93.8M)(167.6M)(275.3M)(439.2M)(653.7M)(621.0M)
Accounts Payable5.5M3.5M3.4M6.9M6.5M3.9M
Cash40.3M93.1M200.7M32.7M54.9M67.8M
Non Current Assets Total7.0M6.0M6.3M7.0M61.2M64.3M
Non Currrent Assets Other82K40K568K37K2M2.1M
Other Assets582K2.8M568K2.0M1.00.95
Cash And Short Term Investments118.4M170.9M333.7M334.4M558.6M586.5M
Net Receivables1.4M1.8M2.0M2.4M9.4M9.8M
Common Stock Shares Outstanding24.2M30.4M38.4M52.0M58.1M33.4M
Liabilities And Stockholders Equity(80.6M)(153.1M)(256.2M)(403.3M)635.4M667.1M
Non Current Liabilities Total4.9M4.0M3.1M8.1M52.3M54.9M
Other Current Assets4.9M4.8M8.1M10.8M6.2M5.0M
Other Stockholder Equity(210.9M)(336.5M)(607.2M)(755.5M)(680.0M)(646.0M)
Total Liab13.2M14.5M19.1M35.8M96.2M101.1M
Property Plant And Equipment Gross6.5M3.2M8.2M9.1M62.5M65.6M
Total Current Assets123.3M177.5M344.7M345.2M574.2M602.9M
Accumulated Other Comprehensive Income148K25K(382K)(3.9M)977K1.0M
Non Current Liabilities Other202K4.8M4.0M2K2.3K2.2K
Common Stock210.8M336.5M607.6M759.4M1.2B1.3B
Property Plant Equipment6.5M5.4M4.7M5.0M5.7M4.2M
Net Invested Capital117.1M168.9M331.9M316.3M539.1M566.1M
Net Working Capital115.0M167.0M328.7M317.5M530.2M556.7M
Short Term Investments78.1M77.8M133.0M301.8M503.7M528.8M
Capital Stock210.8M336.5M607.6M759.4M1.2B1.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Crinetics Stock Analysis

When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.